Patent details

LUC00054 Product Name: Naltrexone or a pharmaceutically acceptable salt thereof, in particular naltrexone hydrochloride, and bupropion or a pharmaceutically acceptable salt thereof, in particular bupropion hydrochloride

Basic Information

Publication number:
LUC00054
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP101857829
Legal Status:
Active
Application number:
LUC00054
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/14/988
Marketing Authorization Type:
Marketing Authorization Date:
30/03/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
11/12/2017
First Marketing Authorization date:
30/03/2015
Grant date:
21/02/2018
Activation date:
21/04/2024
Publication date:
13/12/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/04/2029
SPC Extension Expiration:
21/04/2029
Rejection date:
Withdrawal date:

Owner

From:
11/12/2017
 
 

Name:
Orexigen Therapeutics, Inc.
Address:
3344 North Torrey Pines Court, Suite 200, La Jolla, CA 92037, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
11/12/2017
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/04
Publication date:
23/03/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2024/06
Publication date:
06/05/2024
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
23
Annual Fee Amount:
430 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/04/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
11/12/2017 General Document 2
13/12/2017 Outgoing Correspondence 1
11/12/2017 General Document 3
21/02/2018 Publication 1
21/02/2018 Certificate 1
11/12/2017 General Document 41
11/12/2017 Application Form 5
13/12/2017 Publication 1